Beryl E. Serjeant

1.6k total citations
39 papers, 1.2k citations indexed

About

Beryl E. Serjeant is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Beryl E. Serjeant has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 32 papers in Hematology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Beryl E. Serjeant's work include Hemoglobinopathies and Related Disorders (38 papers), Iron Metabolism and Disorders (29 papers) and Blood groups and transfusion (13 papers). Beryl E. Serjeant is often cited by papers focused on Hemoglobinopathies and Related Disorders (38 papers), Iron Metabolism and Disorders (29 papers) and Blood groups and transfusion (13 papers). Beryl E. Serjeant collaborates with scholars based in Jamaica, Barbados and United Kingdom. Beryl E. Serjeant's co-authors include G. R. Serjeant, Karlene Mason, Yvonne Grandison, Richard Hayes, Douglas R. Higgs, Ian Hambleton, M. Forbes, Janette Lamb, D. J. Weatherall and John Clegg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Beryl E. Serjeant

35 papers receiving 1.1k citations

Peers

Beryl E. Serjeant
Lynn Wynn United States
Brown Ak United States
Mark D. Moncino United States
Jen‐Yih Chu United States
Michaela Brown United Kingdom
Paula K. Groncy United States
Steven J. Culbert United States
C Choremis United States
Lynn Wynn United States
Beryl E. Serjeant
Citations per year, relative to Beryl E. Serjeant Beryl E. Serjeant (= 1×) peers Lynn Wynn

Countries citing papers authored by Beryl E. Serjeant

Since Specialization
Citations

This map shows the geographic impact of Beryl E. Serjeant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beryl E. Serjeant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beryl E. Serjeant more than expected).

Fields of papers citing papers by Beryl E. Serjeant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beryl E. Serjeant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beryl E. Serjeant. The network helps show where Beryl E. Serjeant may publish in the future.

Co-authorship network of co-authors of Beryl E. Serjeant

This figure shows the co-authorship network connecting the top 25 collaborators of Beryl E. Serjeant. A scholar is included among the top collaborators of Beryl E. Serjeant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beryl E. Serjeant. Beryl E. Serjeant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serjeant, G. R., Karlene Mason, Ian Hambleton, & Beryl E. Serjeant. (2023). Acute splenic sequestration in HbSS: observations from the Jamaican birth cohort. Archives of Disease in Childhood. 109(2). 100–105. 1 indexed citations
2.
Serjeant, G. R., Beryl E. Serjeant, & Ian Hambleton. (2021). Retained splenic function in an indian population with homozygous sickle cell disease may have important clinical significance. Indian Journal of Community Medicine. 46(4). 715–715. 10 indexed citations
3.
Serjeant, G. R., Andreas E. Kulozik, & Beryl E. Serjeant. (2021). Odisha Revisited: A Personal Account. Frontiers in Medicine. 8. 745337–745337. 1 indexed citations
4.
Serjeant, G. R., Monika Asnani, Beryl E. Serjeant, et al.. (2018). Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth. PLoS ONE. 13(3). e0192710–e0192710. 36 indexed citations
5.
Mason, Karlene, et al.. (2015). Prevention of sickle cell disease: observations on females with the sickle cell trait from the Manchester project, Jamaica. Journal of Community Genetics. 7(2). 127–132. 5 indexed citations
6.
Serjeant, G. R., Beryl E. Serjeant, Raphael Fraser, et al.. (2011). Hb S-β-Thalassemia: Molecular, Hematological and Clinical Comparisons. Hemoglobin. 35(1). 1–12. 27 indexed citations
7.
Gibson, F. D., Karlene Mason, Beryl E. Serjeant, et al.. (2011). Screening for the beta-thalassaemia trait: hazards among populations of West African Ancestry. Journal of Community Genetics. 3(1). 13–18. 5 indexed citations
8.
Thame, M, Karlene Mason, Douglas R. Higgs, et al.. (2008). The red cell distribution width in sickle cell disease-is it of clinical value?. Clinical & Laboratory Haematology. 13(3). 229–237. 6 indexed citations
9.
Serjeant, G. R., et al.. (2005). Leg Ulceration in Sickle Cell Disease: Medieval Medicine in a Modern World. Hematology/Oncology Clinics of North America. 19(5). 943–956. 51 indexed citations
10.
Wierenga, Klaas J., Beryl E. Serjeant, & G. R. Serjeant. (2001). Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. The Journal of Pediatrics. 139(3). 438–442. 60 indexed citations
11.
Hambleton, Ian, et al.. (2001). Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. British Journal of Haematology. 113(3). 661–665. 95 indexed citations
12.
Serjeant, Beryl E., et al.. (1997). Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: A pilot study. Journal of the American Academy of Dermatology. 37(3). 491–493. 19 indexed citations
13.
Serjeant, Beryl E., et al.. (1996). Determinants of haemoglobin level in steady‐state homozygous sickle cell disease. British Journal of Haematology. 92(1). 143–149. 41 indexed citations
14.
Cook, James D., et al.. (1993). The clinical significance of serum transferrin receptor levels in sickle cell disease. British Journal of Haematology. 84(2). 301–304. 24 indexed citations
15.
Kulozik, Andreas E., et al.. (1991). Sickle cell‐β+ thalassaemia in Orissa State, India. British Journal of Haematology. 77(2). 215–220. 31 indexed citations
16.
Morris, J, David Dunn, Yvonne Grandison, et al.. (1991). The haematology of homozygous sickle cell disease after the age of 40 years. British Journal of Haematology. 77(3). 382–385. 27 indexed citations
17.
Dunn, David, et al.. (1989). Fetal haemoglobin and pregnancy in homozygous sickle cell disease. British Journal of Haematology. 72(3). 434–438. 6 indexed citations
18.
Stevens, Michaël C.G., Hermann Lehmann, Karlene Mason, Beryl E. Serjeant, & G. R. Serjeant. (1982). Sickle cell-Hb Lepore Boston syndrome. Uncommon differential diagnosis to homozygous sickle cell disease.. PubMed. 136(1). 19–22. 3 indexed citations
19.
Higgs, Douglas R., Janette Lamb, John Clegg, et al.. (1982). The Interaction of Alpha-Thalassemia and Homozygous Sickle-Cell Disease. New England Journal of Medicine. 306(24). 1441–1446. 262 indexed citations
20.
Serjeant, G. R., et al.. (1980). Haematological indices in normal negro children: a Jamaican cohort from birth to five years. Clinical & Laboratory Haematology. 2(3). 169–178. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026